APA

Reddy M. M., Fernandes M. S., Deshpande A., Weisberg E., Inguilizian H. V., Abdel-Wahab O., Kung A. L., Levine R. L., Griffin J. D. & Sattler M. (20120508). The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity. : Leukemia.

Chicago

Reddy M M, Fernandes M S, Deshpande A, Weisberg E, Inguilizian H V, Abdel-Wahab O, Kung A L, Levine R L, Griffin J D and Sattler M. 20120508. The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity. : Leukemia.

Harvard

Reddy M. M., Fernandes M. S., Deshpande A., Weisberg E., Inguilizian H. V., Abdel-Wahab O., Kung A. L., Levine R. L., Griffin J. D. and Sattler M. (20120508). The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity. : Leukemia.

MLA

Reddy M M, Fernandes M S, Deshpande A, Weisberg E, Inguilizian H V, Abdel-Wahab O, Kung A L, Levine R L, Griffin J D and Sattler M. The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity. : Leukemia. 20120508.